Compassionate Use of Reslizumab in a Life-threatening Asthma Exacerbation

P Granda; E Villamañán; S Heinz; D Laorden; D Romero; J M Añón; C Carpio; C Sobrino; V Collada; J Domínguez-Ortega; A Herrero; S Quirce; R Álvarez-Sala

doi:10.18176/jiaci.0920

Compassionate Use of Reslizumab in a Life-threatening Asthma Exacerbation

J Investig Allergol Clin Immunol. 2024 Feb 23;34(1):60-61. doi: 10.18176/jiaci.0920. Epub 2023 Jun 21.

Authors

P Granda¹, E Villamañán^{2

3

4}, S Heinz¹, D Laorden^{3

5}, D Romero^{3

6}, J M Añón^{3

7

8}, C Carpio^{3

4

5}, C Sobrino^{2

3}, V Collada^{2

3}, J Domínguez-Ortega^{3

8}, A Herrero^{2

3}, S Quirce⁸, R Álvarez-Sala^{3

4

5}

Affiliations

¹ Pharmacy Department, Hospital Central de la Defensa Gómez- Ulla, Madrid, Spain.
² Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain.
³ IdiPAZ, Madrid, Spain.
⁴ Medicine Department, Universidad Autónoma de Madrid, Spain.
⁵ Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain.
⁶ Intensive Care Unit, Hospital Universitario La Paz, Instituto de Salud Carlos III, Madrid, Spain.
⁷ CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
⁸ Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

PMID: 37357596
DOI: 10.18176/jiaci.0920

No abstract available

Keywords: Critical care; Reslizumab; Severe asthma.

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Asthma* / drug therapy
Compassionate Use Trials*
Humans

Substances

reslizumab
Antibodies, Monoclonal, Humanized